Novo Nordisk
Bagsværd, Denmark · Manufacturing, Science And Engineering
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs abo
Key facts
- Headquarters
- Bagsværd, Denmark
- Employees
- 64,498
- Industries
- Manufacturing, Science And Engineering
- Website
- www.novonordisk.com
- Company page
Recent activity at Novo Nordisk
- : Novo Nordisk Appoints Luigi La Corte as Chief Financial Officer
- : Novo Nordisk and AWS form strategic partnership to enhance drug discovery with AI.
- : 5WPR Partners with Novo to Enhance Brand Visibility for Small Business Solutions
- : Novo Nordisk Partners with OpenAI to Enhance Drug Development and Supply Chain Efficiency.
- : Novo Nordisk Appoints Jamey Millar as EVP of U.S. Operations
- : Novo Nordisk and Aspect Biosystems enhance partnership to develop diabetes cell therapies.
- : Novo Nordisk completes acquisition of Akero Therapeutics
- : Novo Nordisk partners with three telehealth firms to expand Wegovy access
- : Novo Nordisk, Valo Health Announce Expanded $4.6B AI Partnership
- : Novo Nordisk and Ascendis form $285m partnership for once-monthly GLP-1 drug
Leadership
- Luigi La Corte, Chief Financial Officer
- Jamey Millar, Executive Vice President of Operations
- Karsten Munk Knudsen, Chief Financial Officer
- Jacob Martin Wiborg Rode, Vice President of Investor Relations
- Maziar Mike Doustdar, President
Verified email and direct lines for Novo Nordisk’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Novo Nordisk in the news
- Notice Regarding Update to Novo Nordisk’s Hospital and Grantee 340B Distribution Policy - www.novonordisk-us.com (Mar 02, 2026)
- Novo Nordisk (NVO): Company Profile, Stock Price, News, Rankings - Fortune (Sep 23, 2026)
- FDA Approves Oral Wegovy® Pill - www.novonordisk-us.com (Dec 22, 2025)
- Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors - PR Newswire (Nov 05, 2025)
- Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in - GlobeNewswire (Feb 23, 2026)
- Novo Nordisk presents phase 3 data for next-generation - GlobeNewswire (Sep 16, 2025)
- News details - novonordisk-us.com (Nov 05, 2021)
- People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being - GlobeNewswire (Sep 15, 2025)
Companies similar to Novo Nordisk
- Genuine Parts Company · Manufacturing, Science And Engineering
- Advance Auto Parts · Manufacturing, Science And Engineering
- Celestica · Manufacturing, Science And Engineering
- Elbit · Manufacturing, Science And Engineering
- Bombardier · Manufacturing, Science And Engineering
About Novo Nordisk: questions and answers
What does Novo Nordisk do?
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs abo
Where is Novo Nordisk headquartered?
Novo Nordisk is headquartered in Bagsværd, Denmark.
How many employees does Novo Nordisk have?
Novo Nordisk has about 64,498 employees.
Who leads Novo Nordisk?
Jamey Millar is an Executive Vice President of Operations at Novo Nordisk.
What is the latest news on Novo Nordisk?
On Nov 04, 2026, Novo Nordisk Appoints Luigi La Corte as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy